← brief for 2026-11-01 · Slowing decline

Canagliflozin ameliorates ferroptosis in diabetic podocytes by PCBP1-enriched extracellular vesicles derived from proximal tubular epithelial cells.

Article D Peer reviewed Preclinical

Key takeaways

This research shows how the drug canagliflozin protects kidney cells. It works by sending signals from nearby cells to stop a type of cell death. The study used cells and small samples from 60 patients. It was not a test in people, so it does not prove the drug works in the body yet.

Who did this work

Fan X · Song Y · Guo F · Wang Q · Qin Z · Zhou Y · Wang L · Xu F · Shao M · Zheng L · Zhang W · Luo Y

Source

Article · PubMed, the drug frontier · 2026 Nov 1
https://pubmed.ncbi.nlm.nih.gov/42967524/